Medical Developments International Limited (MDDVF)

Market Cap	40.40M -5.0%
Revenue (ttm)	29.45M +9.0%
Net Income	433.07K +566.0%
EPS	0.00 +562.4%
Shares Out	n/a
PE Ratio	93.28
Forward PE	40.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,500
Open	0.3345
Previous Close	0.3700
Day's Range	0.3345 - 0.3345
52-Week Range	0.3038 - 0.3707
Beta	1.41
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About MDDVF

Medical Developments International Limited provides emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The company also supplies respiratory products, including space chambers, peak flow meters, portable nebulizers...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 68
• Stock Exchange: OTCMKTS
• Ticker Symbol: MDDVF

Financial Performance

In fiscal year 2026, MDDVF's revenue was 42.57 million, an increase of 8.99% compared to the previous year's 39.06 million. Earnings were 626,000, an increase of 565.96%.

Financial numbers in AUD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 11, 2026

Data Sources Report a data error